Skip to content
10-Q

Quarterly Report

Akebia Therapeutics, Inc. AKBA

0001628280-25-038600

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 265.15M sh
Shares Diluted Q2 2025 · Jun 30, 2025 271.1M sh
Shares Diluted Q2 2025 · Jun 30, 2025 256.54M sh
Shares Diluted Q2 2025 · Jun 30, 2024 209.71M sh
Shares Diluted Q2 2025 · Jun 30, 2024 207.33M sh
Capex Q2 2025 · Jun 30, 2025 $144K
Capex Q2 2025 · Jun 30, 2024 $29K
Operating Cash Flow Q2 2025 · Jun 30, 2025 $8.76M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$29.5M
Long Term Debt Q2 2025 · Jun 30, 2025 $47.06M
Long Term Debt Q2 2025 · Dec 31, 2024 $38.69M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $137.31M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $51.87M
Stockholders Equity Q2 2025 · Jun 30, 2025 $29.22M
Stockholders Equity Q2 2025 · Mar 31, 2025 $24.58M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$49.19M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$33.75M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$27.26M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$30.58M
Current Liabilities Q2 2025 · Jun 30, 2025 $118.72M
Current Liabilities Q2 2025 · Dec 31, 2024 $80.91M
Total Liabilities Q2 2025 · Jun 30, 2025 $316.37M
Total Liabilities Q2 2025 · Dec 31, 2024 $269.86M
Current Assets Q2 2025 · Jun 30, 2025 $234.66M
Current Assets Q2 2025 · Dec 31, 2024 $113.83M
Total Assets Q2 2025 · Jun 30, 2025 $345.6M
Total Assets Q2 2025 · Dec 31, 2024 $220.67M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2025 $0.02
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.04
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.13
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 $0.03
Eps Basic Q2 2025 · Jun 30, 2024 −$0.04
Eps Basic Q2 2025 · Jun 30, 2024 −$0.13
Sga Expense Q2 2025 · Jun 30, 2025 $26.56M
Sga Expense Q2 2025 · Jun 30, 2025 $52.3M
Sga Expense Q2 2025 · Jun 30, 2024 $26.92M
Sga Expense Q2 2025 · Jun 30, 2024 $52.35M
Rd Expense Q2 2025 · Jun 30, 2025 $11.01M
Rd Expense Q2 2025 · Jun 30, 2025 $20.77M
Rd Expense Q2 2025 · Jun 30, 2024 $7.65M
Rd Expense Q2 2025 · Jun 30, 2024 $17.38M
Net Income Q2 2025 · Jun 30, 2025 $247K
Net Income Q2 2025 · Jun 30, 2025 $6.36M
Net Income Q2 2025 · Mar 31, 2025 $6.11M
Net Income Q2 2025 · Jun 30, 2024 −$8.58M
Net Income Q2 2025 · Jun 30, 2024 −$26.57M
Net Income Q2 2025 · Mar 31, 2024 −$17.99M
Operating Income Q2 2025 · Jun 30, 2025 $14.09M
Operating Income Q2 2025 · Jun 30, 2025 $27.6M
Operating Income Q2 2025 · Jun 30, 2024 −$8.73M
Operating Income Q2 2025 · Jun 30, 2024 −$23.66M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $9.92M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $17.54M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $17.05M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $28.65M
Revenue Q2 2025 · Jun 30, 2025 $62.47M
Revenue Q2 2025 · Jun 30, 2025 $119.81M
Revenue Q2 2025 · Jun 30, 2024 $43.65M
Revenue Q2 2025 · Jun 30, 2024 $76.26M